| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |